Quick Answer
Xtant Medical Holdings, Inc. reported Stockholders Equity of $50.95 million for fiscal year 2025.
Xtant Medical Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $50.95M | +18.6% |
| 2024 | $42.96M | -16.3% |
| 2023 | $51.35M | +50.3% |
| 2022 | $34.17M | +10.6% |
| 2021 | $30.88M | +112.8% |
| 2020 | $14.51M | +132.8% |
| 2019 | -$44.20M | -1.0% |
| 2018 | -$43.77M | +25.4% |
| 2017 | -$58.70M | -729.8% |
| 2016 | -$7.07M | -179.7% |
| 2015 | $8.88M | +214.2% |
| 2014 | -$7.77M | -102.4% |
| 2013 | -$3.84M | -190.8% |
| 2012 | $4.23M | -23.1% |
| 2011 | $5.50M | +988.3% |
| 2010 | -$619.2K | -113.2% |
| 2009 | $4.68M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $50.38M | +10.2% | +3.9% |
| June 30, 2025 | $48.50M | +7.8% | +10.5% |
| March 31, 2025 | $43.88M | -8.0% | +2.1% |
| December 31, 2024 | $42.96M | -16.3% | -6.0% |
| September 30, 2024 | $45.73M | -16.4% | +1.6% |
| June 30, 2024 | $45.01M | +45.4% | -5.6% |
| March 31, 2024 | $47.68M | +45.8% | -7.1% |
| December 31, 2023 | $51.35M | +50.3% | -6.1% |
- Xtant Medical Holdings, Inc. showed an increase of +18.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Xtant Medical Holdings, Inc.’s stockholders equity has grown by 987.6% (from $4.68 million to $50.95 million).
- The most recent figure is from Xtant Medical Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: